Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer

December 06, 2023 00:21:52
Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer
COR2ED - Oncology Medical Conversation
Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer

Dec 06 2023 | 00:21:52

/

Show Notes

Dr. Jaume Capdevila, a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain, and Dr. Rachel van Leeuwaarde, an Endocrinologist from the University Medical Center of Utrecht in The Netherlands discuss the use of multi-kinase inhibitors (MKIs), in particular VEGFR-TKIs in patients with radioactive iodine refractory differentiated thyroid cancer (DTC).

In this podcast, the two experts discuss key trials (SELECT, DECISION and COSMIC-311) and efficacy parameters of the current VEGFR-TKIs (lenvatinib, sorafenib and cabozantinib), how to manage toxicity whilst trying to optimise treatment outcomes and preserving always patients’ quality of life. They also discuss treatment strategies, when to start systemic treatment, which drug should be used first and how to sequence therapies. To close the podcast they take a look at ongoing clinical trials with other treatments in development for DTC.

Other Episodes

Episode

December 06, 2023 00:24:54
Episode Cover

Advanced HCC: Patients not eligible for IO - What are the treatment options?

Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist at the David...

Listen

Episode

December 06, 2023 00:21:28
Episode Cover

Precision oncology: Detection and treatment of TRK fusion-positive lung cancers

In this medical education podcast, NTRK CONNECT members Assoc. Prof. Caterina Marchiò (University of Turin, Italy) and Prof. Christian Rolfo (Center of Thoracic Oncology...

Listen

Episode

December 06, 2023 00:29:54
Episode Cover

Prostate Cancer: Pre-Analytical Phase Challenges and Biomarker Testing

What are the common pre-analytical phase challenges in prostate cancer, and how can we overcome them? Why is it important to identify genetic alterations?...

Listen